3B Blackbio [3BBLACKBIO] vs Zota Health Care [ZOTA] Detailed Stock Comparison

3B Blackbio Diagnostics Ltd.

BSE
Loading...

Zota Health Care Limited

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: 3B Blackbio Diagnostics Ltd. wins in 13 metrics, Zota Health Care Limited wins in 5 metrics, with 0 ties. 3B Blackbio Diagnostics Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric 3B Blackbio Diagnostics Ltd. Zota Health Care Limited Better
P/E Ratio (TTM) 20.80 -62.53 3B Blackbio Diagnostics Ltd.
Price-to-Book Ratio 3.89 12.61 3B Blackbio Diagnostics Ltd.
Debt-to-Equity Ratio 0.09 56.90 3B Blackbio Diagnostics Ltd.
PEG Ratio 0.34 -0.59 3B Blackbio Diagnostics Ltd.
EV/EBITDA 20.17 -126.59 3B Blackbio Diagnostics Ltd.
Profit Margin (TTM) 44.56% -15.37% 3B Blackbio Diagnostics Ltd.
Operating Margin (TTM) 42.39% -15.88% 3B Blackbio Diagnostics Ltd.
EBITDA Margin (TTM) 42.39% N/A N/A
Return on Equity 17.60% -24.83% 3B Blackbio Diagnostics Ltd.
Return on Assets (TTM) 16.13% -12.84% 3B Blackbio Diagnostics Ltd.
Free Cash Flow (TTM) $424.53M $-959.42M 3B Blackbio Diagnostics Ltd.
Dividend Yield N/A 0.07% N/A
1-Year Return -24.89% 12.58% Zota Health Care Limited
Price-to-Sales Ratio (TTM) 9.21 8.34 Zota Health Care Limited
Enterprise Value $11.32B $45.66B Zota Health Care Limited
EV/Revenue Ratio 8.78 9.66 3B Blackbio Diagnostics Ltd.
Gross Profit Margin (TTM) 72.47% 60.28% 3B Blackbio Diagnostics Ltd.
Revenue per Share (TTM) $152 $157 Zota Health Care Limited
Earnings per Share (Diluted) $66.57 $-23.94 3B Blackbio Diagnostics Ltd.
Beta (Stock Volatility) 0.47 0.36 Zota Health Care Limited

3B Blackbio Diagnostics Ltd. vs Zota Health Care Limited Stock Performance Analysis

Loading Price Chart...

3BBLACKBIO
ZOTA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
3B Blackbio Diagnostics Ltd.-0.73%-7.13%-9.11%-6.85%-11.83%-19.55%
Zota Health Care Limited-3.19%9.32%-7.75%1.36%-24.28%-19.38%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
3B Blackbio Diagnostics Ltd.-24.89%58.97%58.97%58.97%58.97%58.97%
Zota Health Care Limited12.58%278.03%548.16%1,137.98%1,137.98%1,137.98%

Performance & Financial Health Analysis: 3B Blackbio Diagnostics Ltd. vs Zota Health Care Limited

Metric3BBLACKBIOZOTA
Market Information
Market Cap i₹11.13B₹39.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i12,50856,411
90 Day Avg. Volume i12,86053,265
Last Close₹1,129.75₹1,186.50
52 Week Range₹1,083.50 - ₹1,750.00₹917.20 - ₹1,740.00
% from 52W High-35.44%-31.81%
All-Time High₹2,350.00 (Dec 09, 2024)₹1,740.00 (Nov 21, 2025)
% from All-Time High-51.93%-31.81%
Growth Metrics
Quarterly Revenue Growth0.98%0.98%
Quarterly Earnings Growth0.62%1.12%
Financial Health
Profit Margin (TTM) i0.45%-0.15%
Operating Margin (TTM) i0.42%-0.16%
Return on Equity (TTM) i0.18%-0.25%
Debt to Equity (MRQ) i0.0956.90
Cash & Liquidity
Book Value per Share (MRQ)₹355.75₹103.04
Cash per Share (MRQ)₹27.44₹1.87
Operating Cash Flow (TTM) i₹619.97M₹-1,007,999,000
Levered Free Cash Flow (TTM) i₹476.91M₹-563,984,000
Dividends
Last 12-Month Dividend Yield iN/A0.07%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: 3B Blackbio Diagnostics Ltd. vs Zota Health Care Limited

Metric3BBLACKBIO (Apr 24, 2026)ZOTA (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i20.80-62.53
Forward P/E iN/AN/A
PEG Ratio i0.34-0.59
Price to Sales (TTM) i9.218.34
Price to Book (MRQ) i3.8912.61
Market Capitalization
Market Capitalization i₹11.13B₹39.41B
Enterprise Value i₹11.32B₹45.66B
Enterprise Value Metrics
Enterprise to Revenue i8.789.66
Enterprise to EBITDA i20.17-126.59
Risk & Other Metrics
Beta i0.470.36
Book Value per Share (MRQ) i₹355.75₹103.04

Financial Statements Comparison: 3B Blackbio Diagnostics Ltd. vs Zota Health Care Limited

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric3BBLACKBIO (2025)ZOTA (2025)
Revenue/Sales i964.69M2.93B
Cost of Goods Sold i256.46M1.44B
COGS % of Revenue i26.6%49.0%
Gross Profit i708.23M1.49B
Gross Margin i73.4%51.0%
Research & Development i5.12MN/A
Operating Income (EBIT) i493.22M-480.90M
Operating Margin i51.1%-16.4%
EBITDA i591.08M-42.20M
EBITDA Margin i61.3%-1.4%
Pre-Tax Income i639.98M-576.44M
Pre-Tax Income % of Revenue i66.3%-19.7%
Income Tax i163.07M-9.06M
Income Tax % of Revenue i16.9%-0.3%
Net Income (Profit) i476.91M-567.39M
Profit Margin i49.4%-19.4%

Balance Sheet & Liquidity Metrics

Metric3BBLACKBIO (2025)ZOTA (2025)
Cash & Equivalents i117.07M21.32M
Total Current Assets i1.32B1.84B
Total Current Assets % of Revenue i137.0%62.9%
Total Current Liabilities i185.88M1.01B
Total Current Liabilities % of Revenue i19.3%34.3%
Long-Term Debt i3.07M1.08B
Long-Term Debt % of Revenue i0.3%36.7%
Total Shareholders Equity i2.71B2.27B
Retained Earnings i2.51B-191.89M
Retained Earnings % of Revenue i259.9%-6.5%
Property, Plant & Equipment i85.37M65.25M

Cash Flow Statement Comparison

Metric3BBLACKBIO (2025)ZOTA (2025)
Operating Cash Flow i619.97M-1.01B
Operating Cash Flow % of Revenue i64.3%-34.4%
Capital Expenditures i-9.04M-459.67M
Free Cash Flow i424.53M-959.42M
FCF Margin i44.0%-32.7%
Debt Repayment i-5.44M-140.67M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

Metric3BBLACKBIOZOTA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i8.58M30.33M
Float Shares i2.69M15.02M
% Held by Insiders i65.90%0.00%
% Held by Institutions i1.95%1.16%
% Held by Public i32.15%98.84%

Dividend Analysis & Yield Comparison: 3B Blackbio Diagnostics Ltd. vs Zota Health Care Limited

Metric3BBLACKBIOZOTA
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.07%
3-Year Avg Annual Dividend iN/A₹1.00
3-Year Avg Dividend Yield iN/A0.16%
3-Year Total Dividends iN/A₹3.00
Ex-Dividend DateN/ASep 22, 2025